X-50067761-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_001127898.4(CLCN5):c.164-2118G>T variant causes a intron change. The variant allele was found at a frequency of 0.000131 in 747,085 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 26 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.00015 ( 0 hom. 25 hem. )
Consequence
CLCN5
NM_001127898.4 intron
NM_001127898.4 intron
Scores
1
1
Splicing: ADA: 0.8039
1
1
Clinical Significance
Conservation
PhyloP100: 5.32
Genes affected
CLCN5 (HGNC:2023): (chloride voltage-gated channel 5) This gene encodes a member of the ClC family of chloride ion channels and ion transporters. The encoded protein is primarily localized to endosomal membranes and may function to facilitate albumin uptake by the renal proximal tubule. Mutations in this gene have been found in Dent disease and renal tubular disorders complicated by nephrolithiasis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.00015 (95/635347) while in subpopulation NFE AF= 0.000158 (92/581029). AF 95% confidence interval is 0.000131. There are 0 homozygotes in gnomad4_exome. There are 25 alleles in male gnomad4_exome subpopulation. Median coverage is 15. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAdExome4 at 25 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCN5 | NM_001127898.4 | c.164-2118G>T | intron_variant | ENST00000376091.8 | NP_001121370.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCN5 | ENST00000376108.7 | c.-48+1G>T | splice_donor_variant | 1 | ENSP00000365276 | A1 | ||||
CLCN5 | ENST00000376091.8 | c.164-2118G>T | intron_variant | 2 | NM_001127898.4 | ENSP00000365259 | P3 | |||
CLCN5 | ENST00000376088.7 | c.164-2118G>T | intron_variant | 2 | ENSP00000365256 | P3 | ||||
CLCN5 | ENST00000643129.1 | c.*261-2118G>T | intron_variant, NMD_transcript_variant | ENSP00000496056 |
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 111738Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33904
GnomAD3 genomes
AF:
AC:
3
AN:
111738
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33904
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000150 AC: 95AN: 635347Hom.: 0 Cov.: 15 AF XY: 0.000134 AC XY: 25AN XY: 187041
GnomAD4 exome
AF:
AC:
95
AN:
635347
Hom.:
Cov.:
15
AF XY:
AC XY:
25
AN XY:
187041
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000268 AC: 3AN: 111738Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33904
GnomAD4 genome
AF:
AC:
3
AN:
111738
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33904
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 28, 2023 | - - |
Dent disease type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 11, 2018 | This variant occurs in a canonical splice site (donor) and is therefore predicted to disrupt or distort the normal gene product. It was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018) and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score for this variant, it could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene and cDNA change. No publications were found based on this search. Due to the potential impact of splice donor variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at